文献速递主动脉疾病外周动脉疾病颈动脉与弓上血管

常见血管手术后阿片类药物处方的患者与机构因素

Patient and institutional factors associated with postoperative opioid prescribing after common vascular procedures.
PubMed 文献 · J Vasc Surg · 2019-09-10

本研究纳入1546例未使用过阿片类药物的血管手术患者,分析出院阿片处方的影响因素。结果显示48%患者获得出院阿片处方,23%患者出院吗啡毫克当量(MME)超过200。年轻年龄、治疗机构、住院时间、吸烟史与高MME处方相关,机构间差异提示处方缺乏标准化。

要点

  • 48%的未使用过阿片类药物的血管手术患者获得出院阿片处方,其中23%的MME超过200。
  • 年轻患者(<65岁)、治疗机构B或C、住院时间位于手术特异性最高四分位、既往吸烟史与MME>200相关。
  • 不同手术类型MME差异显著,腹股沟上/下 bypass最高(中位数225/200),颈动脉支架、颈动脉内膜切除和经皮外周血管介入最低(中位数0)。

核心结论

  • 出院阿片处方随血管手术侵入性不同而变化,机构间差异提示处方实践缺乏标准化。

研究设计与样本

  • 回顾性队列研究,纳入2015-2017年某整合医疗系统中1546例未使用过阿片类药物、接受九种血管手术的患者,匹配出院和续方阿片处方。

主要发现

  • 739例(48%)获得出院阿片处方,中位MME为0(IQR 0-150),349例(23%)MME>200。
  • 在有出院处方的患者中,中位MME为180(IQR 150-300)。
  • MME随手术类型变化(P < .001),腹股沟上bypass中位225,腹股沟下bypass中位200,颈动脉支架、颈动脉内膜切除和经皮外周血管介入中位均为0。
  • 多变量分析中,MME>200的相关因素包括年龄<65岁 vs ≥80岁(OR 3.0;95%CI 1.9-4.6;P < .001)、治疗机构B vs A(OR 3.50;95%CI 2.42-5.07;P < .001)和C vs A(OR 3.90;95%CI 2.66-5.74;P < .001)、手术特异性住院时间最高四分位(OR 1.45;95%CI 1.01-2.08;P = .047)、既往吸烟(OR 1.60;95%CI 1.07-2.37;P = .02)。
  • 当前吸烟和术前未使用阿司匹林也与出院时手术特异性最高四分位MME相关;长期使用β受体阻滞剂对最高四分位MME有保护作用。

关键数值与推荐

  • 术后阿片处方建议限制在7天以内或<200 MME。
  • 基于观察到的变异性,已制定机构阿片处方标准以促进标准化。

临床怎么用

  • 临床医生应关注年轻、有吸烟史、住院时间较长及特定机构出院的患者,这些因素提示高MME处方风险。
  • 可根据手术类型和患者因素调整出院阿片处方,参考机构标准减少变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Overprescription of postoperative opioid medication is a major contributor to the opioid abuse epidemic in the United States. Research into prescribing practices has suggested that patients be limited to 7 days or <200 morphine milligram equivalents (MME) after surgical procedures. Our aim was to identify patient or institutional factors associated with increased opioid prescriptions. METHODS: Opioid naive patients from an integrated health system undergoing one of nine surgical and endovascular procedures tracked within the Vascular Quality Initiative from 2015 to 2017 were identified and matched to their discharge and refill opioid prescriptions. Discharge opioid prescriptions were converted to MME. The primary outcome was discharge MME >200, and secondary outcomes were procedure-specific top-quartile opioid prescription and medication refills. Multivariable logistic regression was used to assess patient and perioperative factors associated with each outcome. RESULTS: Among 1546 opioid naive patients, 739 (48%) received a discharge opioid prescription; median MME was 0 (interquartile range, 0-150), and 349 (23%) had >200 MME. Among those with a discharge prescription, median MME was 180 (interquartile range, 150-300). MME varied by procedure (P < .001), with highest MME after suprainguinal bypass (median, 225) and infrainguinal bypass (200) and lowest MME after carotid artery stenting, carotid endarterectomy, and percutaneous peripheral vascular intervention (all medians of 0). On multivariable analysis, factors associated with MME >200 included younger patient age (<65 vs ≥ 80 years; odds ratio [OR], 3.0; 95% confidence interval [CI], 1.9-4.6; P < .001), treating institution B vs A (OR, 3.50; 95% CI, 2.42-5.07; P < .001) and C vs A (OR, 3.90; 95% CI, 2.66-5.74; P < .001), procedure-specific top-quartile length of stay (OR, 1.45; 95% CI, 1.01-2.08; P = .047), and prior tobacco use (OR, 1.60; 95% CI, 1.07-2.37; P = .02). The same variables along with current tobacco use and lack of preoperative aspirin were associated with procedure-specific top-quartile MME at discharge. Chronic beta-blocker use was protective of top-quartile MME. Based on the observed variability, an institutional standard for opioid prescribing has been developed for standardization. CONCLUSIONS: Opioid prescriptions at discharge vary with the invasiveness of vascular surgical procedures. Less than 25% of patients receive >200 MME. Variation by center represents a lack of standardization in prescribing practices and an opportunity for further improvement based on developed guidelines. Patient factors and procedure type can alert clinicians to patients at risk of higher than recommended MME.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gifford ED, Hanson KT, Davila VJ, et al. Patient and institutional factors associated with postoperative opioid prescribing after common vascular procedures. J Vasc Surg. 2019. PMID: 31519513. doi:10.1016/j.jvs.2019.05.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。